SENS 2 Early Registration Deadline, June 15th

If you want to get in under the early registration deadline for the Second Strategies for Engineered Negligible Senescence (SENS) Conference in September then you are cutting it fine - your chance to save money on the registration fee is gone after June 15th.

The purpose of the SENS conference series, like all the SENS initiatives (such as the journal Rejuvenation Research and the Methuselah Mouse Prize), is to expedite the development of truly effective therapies to postpone and treat human aging by tackling it as an engineering problem: not seeking elusive and probably illusory magic bullets, but instead enumerating the accumulating molecular and cellular changes that eventually kill us and identifying ways to repair - reverse - those changes, rather than merely to slow down their further accumulation.

The SENS 2 program as it stands right now promises a good conference - you'll see many familiar names and promising fields of science if you're someone who keeps tabs on biogerontology and other aging research. The Ellison Medical Foundation session on the removal of intracellular waste products - a growing area of interest in the medical research community - looks to be particularly fascinating.

Also of note:

This year's SENS Lecture, provisionally entitled "Stem cells, SCNT and the rejuvenation imperative", will be given by Dr. Michael West, CEO of Advanced Cell Technology.